oktober 1, 2019
Cambridge, UK and Indianapolis, US – 1 October 2019: Acacia Pharma Group plc (the “Company), (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialisation of new nausea and vomiting treatments for surgical and cancer patients, announces that application has been made to Euronext Brussels for the admission in aggregate of 303,841 Ordinary Shares...


Lundbeckfonden giver 60 mio. kr. til dristige videnskabelige ideer
11. december 2019
Seks hjerneprofessorer får 232 mio. kr.
10. december 2019
Vil lave system der advarer mod fødselsdepression
19. november 2019


Lundbeckfonden Ventures

Lundbeckfonden Emerge